Literature DB >> 18635554

Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction.

Nathan J Palpant1, Sharlene M Day, Todd J Herron, Kimber L Converso, Joseph M Metzger.   

Abstract

AIMS: Contractile dysfunction associated with myocardial ischaemia is a significant cause of morbidity and mortality in the elderly. Strategies to protect the aged heart from ischaemia-mediated pump failure are needed. We hypothesized that troponin I-mediated augmentation of myofilament calcium sensitivity would protect cardiac function in aged mice. METHODS AND
RESULTS: To address this, we investigated transgenic (Tg) mice expressing a histidine-substituted form of adult cardiac troponin I (cTnI A164H), which increases myofilament calcium sensitivity in a pH-dependent manner. Serial echocardiography revealed that Tg hearts showed significantly improved systolic function at 4 months, which was sustained for 2 years based on ejection fraction and velocity of circumferential fibre shortening. Age-related diastolic dysfunction was also attenuated in Tg mice as assessed by Doppler measurements of the mitral valve inflow and lateral annulus Doppler tissue imaging. During acute hypoxia, cardiac contractility significantly improved in aged Tg mice made evident by increased stroke volume, end systolic pressure, and +dP/dt compared with non-transgenic mice.
CONCLUSION: This study shows that increasing myofilament function by means of a pH-responsive histidine button engineered into cTnI results in enhanced baseline heart function in Tg mice over their lifetime, and during acute hypoxia improves survival in aged mice by maintaining cardiac contractility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635554      PMCID: PMC2567875          DOI: 10.1093/cvr/cvn198

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  36 in total

1.  Burden of disease--implications for future research.

Authors:  C M Michaud; C J Murray; B R Bloom
Journal:  JAMA       Date:  2001-02-07       Impact factor: 56.272

Review 2.  Troponin I isoforms and chimeras: tuning the molecular switch of cardiac contraction.

Authors:  M V Westfall; J M Metzger
Journal:  News Physiol Sci       Date:  2001-12

3.  Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure.

Authors:  F del Monte; R J Hajjar; S E Harding
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

Review 4.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

Review 5.  Calcium cycling in congestive heart failure.

Authors:  Gerd Hasenfuss; Burkert Pieske
Journal:  J Mol Cell Cardiol       Date:  2002-08       Impact factor: 5.000

6.  Single mutation (A162H) in human cardiac troponin I corrects acid pH sensitivity of Ca2+-regulated actomyosin S1 ATPase.

Authors:  Roland Dargis; Joyce R Pearlstone; Isabelle Barrette-Ng; Helena Edwards; Lawrence B Smillie
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

7.  Chimera analysis of troponin I domains that influence Ca(2+)-activated myofilament tension in adult cardiac myocytes.

Authors:  M V Westfall; F P Albayya; I I Turner; J M Metzger
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

Review 8.  Calcium and cardiomyopathies.

Authors:  E G Kranias; D M Bers
Journal:  Subcell Biochem       Date:  2007

Review 9.  Perspectives on mammalian cardiovascular aging: humans to molecules.

Authors:  Edward G Lakatta; Steven J Sollott
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2002-08       Impact factor: 2.320

10.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

View more
  12 in total

1.  Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.

Authors:  Jennifer Davis; Soichiro Yasuda; Nathan J Palpant; Joshua Martindale; Tamara Stevenson; Kimber Converso; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2012-06-06       Impact factor: 5.000

2.  Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies.

Authors:  Nathan J Palpant; Fikru B Bedada; Brandon Peacock; Bruce R Blazar; Joseph M Metzger; Jakub Tolar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

3.  Molecular determinants of cardiac myocyte performance as conferred by isoform-specific TnI residues.

Authors:  Brian R Thompson; Evelyne M Houang; Yuk Y Sham; Joseph M Metzger
Journal:  Biophys J       Date:  2014-05-20       Impact factor: 4.033

4.  Measuring Pressure Volume Loops in the Mouse.

Authors:  DeWayne Townsend
Journal:  J Vis Exp       Date:  2016-05-02       Impact factor: 1.355

Review 5.  Cell biology of sarcomeric protein engineering: disease modeling and therapeutic potential.

Authors:  Brian R Thompson; Joseph M Metzger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

6.  Cytoplasmic nucleic acid-based XNAs directly enhance live cardiac cell function by a Ca2+ cycling-independent mechanism via the sarcomere.

Authors:  Brian R Thompson; Kailey J Soller; Anthony Vetter; Jing Yang; Gianluigi Veglia; Michael T Bowser; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2019-03-05       Impact factor: 5.000

7.  Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes.

Authors:  Adam B Stein; Thomas A Jones; Todd J Herron; Sanjeevkumar R Patel; Sharlene M Day; Sami F Noujaim; Michelle L Milstein; Matthew Klos; Philip B Furspan; José Jalife; Gregory R Dressler
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

8.  Pathogenic peptide deviations support a model of adaptive evolution of chordate cardiac performance by troponin mutations.

Authors:  Nathan J Palpant; Evelyne M Houang; Wayne Delport; Kenneth E M Hastings; Alexey V Onufriev; Yuk Y Sham; Joseph M Metzger
Journal:  Physiol Genomics       Date:  2010-04-27       Impact factor: 3.107

9.  Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo.

Authors:  Nathan J Palpant; Louis G D'Alecy; Joseph M Metzger
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

Review 10.  Molecular cardiology in translation: gene, cell and chemical-based experimental therapeutics for the failing heart.

Authors:  Immanuel Turner; Fikru Belema-Bedada; Joshua Martindale; Dewayne Townsend; Wang Wang; Nathan Palpant; So-Chiro Yasuda; Matthew Barnabei; Ekaterina Fomicheva; Joseph M Metzger
Journal:  J Cardiovasc Transl Res       Date:  2008-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.